Cargando…
Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis
Background: Despite the benefits of trastuzumab in many trials, evidence of its impact on health-related quality of life (HRQoL) in early treatment has not been summarized. This study explored the effects of trastuzumab treatment on HRQoL, including pooled meta-analysis, in an effort to provide an i...
Autores principales: | Khoirunnisa, Sudewi Mukaromah, Suryanegara, Fithria Dyah Ayu, Setiawan, Didik, Postma, Maarten Jacobus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140570/ https://www.ncbi.nlm.nih.gov/pubmed/37124232 http://dx.doi.org/10.3389/fphar.2023.1090326 |
Ejemplares similares
-
Facing problems in radiotherapy for breast cancer patients in Yogyakarta, Indonesia: A cohort retrospective study
por: Suryanegara, Fithria Dyah Ayu, et al.
Publicado: (2023) -
Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
por: Yang, Jiangping, et al.
Publicado: (2022) -
Prevention of Surgical Site Infections: A Systematic Review of Cost Analyses in the Use of Prophylactic Antibiotics
por: Purba, Abdul K. R., et al.
Publicado: (2018) -
Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
por: Li, Zongyu, et al.
Publicado: (2023) -
Clinical pharmacy services for tuberculosis management: a systematic review
por: Iskandar, D., et al.
Publicado: (2023)